Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
MEDIBANK PRIVATE LIMITED (MPL)ASX AI Signals has generated 6 signals for MPL during the last 90 days, indicating strong trading activity and ongoing AI monitoring
Latest MPL Signals | |
| 26/06/2026 | BUY |
| 12/06/2026 | BUY |
| 20/05/2026 | BUY |
MPL Share Price | |
| Current Price | $5.000 |
| 52 Week High | $5.055 |
| 52 Week Low: | $4.100 |
| Trading at (% of 52 Week High) | 98.91% |
Medibank Private Limited (ASX: MPL) is an Australian private health insurer that provides health and wellness services to individuals and families. The company offers a range of health insurance products, including hospital, extras, and ambulance cover, aiming to support members' healthcare needs. Medibank also delivers health advice and related services to promote wellbeing.
The Insurance sector on the ASX consists of companies that provide risk management products and services, including life, health, property, and casualty insurance. These firms collect premiums from customers and pay claims in the event of insured losses. The sector also covers reinsurance firms that offer insurance to other insurers. It plays a key role in protecting individuals and businesses against financial losses from accidents, natural disasters, illness, and other risks. Insurers are regulated to ensure they maintain sufficient reserves to meet claims obligations.
The BUY recommendation for MEDIBANK PRIVATE LIMITED (MPL) is supported by strong fundamentals and positive market sentiment. The current price of 4.9900 reflects a favorable entry point with potential upside. However, some sector-specific risks and market volatility warrant caution.
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, the Medibank Private Limited (ASX:MPL) share price is up 80% in the last 5 years, clearly besti Key Insights
Significant control over Medibank Private by individual investors implies that the general public has more power to influence management and governance-related decisions 43% of the business is held by the top 25 shareholders Insiders have bought recently
AI is about to change healthca Medibank Private Limited's (ASX:MPL) dividend will be increasing from last year's payment of the same period to A$0.102 on 9th of October. This takes the annual payment to 3.5% of the current stock price, which is about average for the industry.
This technology could replace computers: discover the Key Insights
The considerable ownership by individual investors in Medibank Private indicates that they collectively have a greater say in management and business strategy A total of 25 investors have a majority stake in the company with 41% ownership Institutions own 44% of Medibank Private
Our f The Australian market has shown mixed performance recently, with the ASX200 experiencing a slight uptick, closing up 0.07% at 7,942 points, and sectors like IT and Health Care leading the gains. In this environment of sector-specific fluctuations, investors often look to dividend stocks for their poLatest MEDIBANK PRIVATE LIMITED(MPL) News
Medibank Private's (ASX:MPL) investors will be pleased with their splendid 121% return over the last five years
Institutions own 46% of Medibank Private Limited (ASX:MPL) shares but individual investors control 54% of the company
Medibank Private (ASX:MPL) Is Paying Out A Larger Dividend Than Last Year
While institutions own 44% of Medibank Private Limited (ASX:MPL), individual investors are its largest shareholders with 56% ownership
3 ASX Dividend Stocks With Yields Up To 6.6%
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial